Clean Tech Developer Sees Massive Opportunity in PFAS Treatment
Source: Streetwise Reports  (1/29/26)
BioLargo Inc. (BLGO:OTCQX) announces that its patented Aqueous Electrostatic Concentrator (AEC) PFAS treatment system has been installed in New Jersey. Find out why the company sees massive upside for its products. More >

Environmental Firm Finds High-Value Position in PFAS Remediation Industry
Source: Streetwise Reports  (1/28/26)
BioLargo Inc. (BLGO:OTCQX) has announced the installation of its patented Aqueous Electrostatic Concentrator (AEC) PFAS treatment system in New Jersey. Discover why the company anticipates significant potential for its products. More >

Tech Firm Partners to Advance AI-Powered Support for MDs
Source: Streetwise Reports  (12/11/25)
Rocket Doctor AI Inc.'s (AIDR:CSE; TREIF:OTC; 939:FRA) Clinical Decision Support System is being deployed in Alberta, Canada, on a small scale for a trial period with the goal of expanding it province-wide next year. This company's stock is rated Speculative Buy; read on to learn why. More >

Clean Tech Co.: Wound Care Subsidiary Set to Take Off; 3Q Results
Source: Streetwise Reports  (11/19/25)
Clean technology innovation company BioLargo Inc. releases its financial and operational results for the three- and nine-month periods ending September 30. It also has announced an agreement to distribute its cutting-edge wound irrigation solution nationally. More >

AI Cancer Discovery Shows Breakthrough in Brain-Targeting Treatment
Source: Streetwise Reports  (10/20/25)
Rakovina Therapeutics Inc. (RKV:TSX.V) is set to unveil new preclinical data from its AI-driven ATR inhibitor program at a major international cancer conference in Boston. The findings highlight strong efficacy and blood-brain barrier permeability, a potential breakthrough for hard-to-treat tumors and brain metastases. More >

Healthcare Tech Firm Finds Big U.S. Opportunity
Source: Streetwise Reports  (10/9/25)
Healthcare data firm OneMedNet Corporation (Nasdaq: ONMD) partners with Palantir Technologies Inc. (PLTR:NASDAQ) to analyze over 5 billion claims and 131 million exams, unlocking a possible massive U.S. breakthrough in AI-driven research. More >

Biotech Firm Uncovers Breakthrough Gene Therapy in New York
Source: Streetwise Reports  (10/9/25)
Lexeo Therapeutics Inc. (LXEO:NASDAQ) advanced its LX2006 program after new FDA feedback supported an accelerated approval path. Read how interim data showed strong cardiac and neurological improvements, prompting bullish analyst upgrades. More >

Clean Tech Co.'s 'Forever Chemical' Solution Is a PFAS Breakthrough
Source: Streetwise Reports  (10/2/25)
Clean technology company BioLargo Inc. (BLGO:OTCQX) announced compelling new findings about its proprietary Aqueous Electrostatic Concentration (AEC) "forever chemicals" solution. Read to discover why one expert thinks the breakthrough is important to the company's future. More >

Healthcare AI Company Rebrands as Rocket Doctor AI to Pursue Growing Market Opportunities
Source: Streetwise Reports  (8/27/25)
Treatment.com AI Inc. has rebranded and reincorporated as Rocket Doctor AI (AIDR:CSE; TREIF:OTC; 939:FRA) to reflect the integration of its proprietary AI-driven Global Library of Medicine (GLM) with the recently acquired Rocket Doctor Inc. Read why one analyst calls part of the company's offerings "Shopify for physicians." More >

AI-Powered Medical Education Suite Cuts Costs, whilst Enhancing Clinical Skills Training for Future Doctors
Source: Streetwise Reports  (6/16/25)
Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) launched its enhanced medical education suite in Minnesota, showing strong reliability and providing schools with up to 40% cost savings. Read on to find out how AI-simulated patients are reshaping medical education and enhancing clinical skills at scale. More >

Treatment.com AI's Rocket Doctor Expands US Reach and Drives New Growth Through Virtual ER Innovation
Source: Streetwise Reports  (5/23/25)
Treatment.com AI Inc.'s (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) virtual care subsidiary, Rocket Doctor, has expanded its core virtual care services into New York and California. Separately, its virtual ER program, designed to reduce unnecessary emergency room visits, continues to demonstrate a strong impact. Over a 12-month period between 2023 and 2024, Rocket Doctor reported an 88% year-over-year increase in revenue." More >

AI Study Tracks Unexpected Cognitive Gains in Vascular Dementia Trial
Source: Streetwise Reports  (3/11/25)
Hemostemix Inc.'s (HEM:TSXV; HMTXF:OTCQB; 2VF0:FSE) Phase 1 trial, in collaboration with Firefly Neuroscience Inc. (AIFF:NASDAQ), is evaluating ACP-01s impact on vascular dementia using AI-driven brain analysis. Early insights could reshape treatment approaches. More >

Canadian Healthcare Co. Showcases Stable FQ424
Source: Dr. Douglas Loe  (3/6/25)
Leede Financial Inc. raised its target price on CareRX Corp. (CRRX:TSX; CHHHF:OTCMKTS). Read on to see why one Leede analyst rates the stock as a Buy. More >

Virtual Healthcare Breakthrough Expanding Access for 6.9M Medicaid Patients in New York
Source: Streetwise Reports  (2/27/25)
Rocket Doctor, under Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA), is now an in-network provider for New York Medicaid, expanding virtual healthcare access to 6.9 million beneficiaries. Find out how this milestone offers the possibility to reshape healthcare accessibility.

More >

Healthcare Tech Co. To Acquire Digital Health Platform
  (2/13/25)
This will expand its ecosystem of AI-powered products. Read on to learn more about its offerings and rapidly growing sector. More >

New Strategic Moves Aim To Accelerate Growth in AI Healthcare
Source: Streetwise Reports  (2/12/25)
Light AI Inc. (ALGO:CBOE) announces major marketing campaigns, advisory board appointments, and a key regulatory partnership to drive growth. Discover how these strategic moves could shape the future of AI healthcare.

More >

Kentucky Medical Co. Has Strong Operating Fundamentals
Source: Douglas Loe  (2/12/25)
Quipt Home Medical Corp. (QIPT:NASDAQ; QIPT:TSX.V) received a lowered price target but a Buy rating from a Leede Financial Inc. research note. More >

Should You Double Down on This Story Stock?
Source: Chris Temple  (1/7/25)
Chris Temple of The National Investor explains why he believes you might want to double down on BioLargo Inc. (BLGO:OTCQX). More >

Is This Centrally Positioned AI Healthcare Co. Set to Transform the Industry?
Source: Clive Maund  (12/20/24)
Technical Analyst Clive Maund explains why he thinks Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) offers potential upside to investors. More >

New Quebec Law Affecting Healthcare Co.'s Bottom Line
Source: Douglas Lowe  (12/16/24)
Quebec-based staffing operator Premier Health of America Inc. (PHA:TSX.V) reported soft financial data for the fourth quarter of 2024 as the province's Bill 10 act limiting the use of per diem operations. Find out why this analyst thinks things will improve for the company. More >

Revolutionary AI Tools Take Center Stage in Medical Education Symposium
Source: Streetwise Reports  (11/5/24)
Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) has announced the release of its newly updated Medical Education Suite (MES). Read more to find out how this update is set to transform medical education and enhance training efficiency.

More >

Medical Co. Ready for a Transformative F2025
Source: Dr. Douglas Loe  (11/5/24)
The Leede Financial Inc. analyst also noted that while F2024 is a transition year for Profound Medical Corp. (PROF:NASDAQ; PRN:TSX), F2025 is expected to be transformative for U.S. TULSA-PRO adoption. rates. More >

AI Healthcare Co. With 'Bright' Outlook Closes Placement
Source: Streetwise Reports  (10/31/24)
Healthcare artificial intelligence (AI) company Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) has closed a non-brokered private placement for aggregate gross proceeds of CA$1.95 million. Find out why one analyst says the stock is a Strong Buy and worth going overweight on. More >

Is This AI Healthcare Stock Worth Being Overweight On?
Source: Clive Maund  (10/9/24)
Technical Analyst Clive Maund explains why he thinks Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) is a Strong Buy and worth being overweight on. More >

AI Collaboration to Streamline Healthcare Administration and Improve Patient Outcomes
Source: Streetwise Reports  (9/19/24)
Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) has formally entered a collaborative agreement with UK-based AI healthcare technology company SPRYT Limited. Read how this partnership aims to change the way patients interact with their healthcare providers. More >